Swope David M
Department of Neurology, Loma Linda University, Loma Linda, California 92354, USA.
Neurology. 2004 Mar 23;62(6 Suppl 4):S27-31. doi: 10.1212/wnl.62.6_suppl_4.s27.
Patients with advanced Parkinson's disease (PD) may develop a variety of motor complications associated with levodopa therapy. Motor fluctuations, such as early morning akinesia and "wearing-off," may respond to individualized medical management with titrated combinations of levodopa, dopamine agonists, COMT inhibitors and amantadine. Often with disease progression, dyskinesias and unpredictable, rapid "off" periods will also emerge. These motor complications are less amenable to traditional anti-parkinson therapy manipulation. This manuscript reviews approaches for "rescue" therapy in PD patients with "wearing off," sudden "offs," early morning akinesia, and variable response to individual doses of oral medications. Strategies for preparing and administering liquid levodopa are discussed within the context of gastric emptying, intestinal absorption, and active transport across the blood brain barrier. In addition other levodopa preparations in early development, including the orally administered levodopa methyl ester and the potential for a subcutaneously administered levodopa ethyl ester are reviewed. Furthermore, practical guidelines regarding the dosing, administration, use of the antiemetic trimethobenzamide (Tigan), time to "on," duration of benefit, and potential side effects associated with subcutaneously injected apomorphine are provided.
晚期帕金森病(PD)患者可能会出现与左旋多巴治疗相关的多种运动并发症。运动波动,如清晨运动不能和“剂末现象”,可能通过左旋多巴、多巴胺激动剂、儿茶酚-O-甲基转移酶(COMT)抑制剂和金刚烷胺的个体化滴定联合药物治疗得到缓解。随着疾病进展,异动症和不可预测的快速“关”期也常常会出现。这些运动并发症较难通过传统的抗帕金森病治疗手段进行处理。本文综述了针对出现“剂末现象”、突然“关”期、清晨运动不能以及对口服单剂量药物反应多变的PD患者的“挽救”治疗方法。在胃排空、肠道吸收以及跨越血脑屏障的主动转运背景下,讨论了液体左旋多巴的配制和给药策略。此外,还综述了其他处于早期研发阶段的左旋多巴制剂,包括口服的左旋多巴甲酯以及皮下注射左旋多巴乙酯的可能性。此外,还提供了关于皮下注射阿扑吗啡的剂量、给药、使用止吐药三甲氧苯酰胺(胃复安)、起效时间、获益持续时间以及潜在副作用的实用指南。